Riskpilot← Back to searchSign inGet full accessScandinavian House AB
ABBankruptOrg 5568077431Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20100 employees
Revenue 2021
SEK 0
EBITDA margin
—
-130% vs 2020
Equity ratio
64.9%
Financial strength
Net profit 2021
SEK -82K
-132% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -79K | -130% |
| Net profit | SEK -82K | -132% |
| Total assets | SEK 1,9M | +0% |
| Equity | SEK 1,2M | -6% |
| Employees | 0 | — |
Legal name
Scandinavian House AB
Org number
5568077431
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6 maj 2010
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall utveckla mjukvara, producera och marknadsföra informations- och mediaprodukter samt bedriva e-handel och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 606 | 459 | 196 | 323 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −42 | −12 | −59 | 262 | −79 |
| Depreciation & amort. | −4 | −0 | −0 | −0 | −0 |
| EBIT | −46 | −12 | −59 | 262 | −79 |
| Net financials | −69 | 22 | −8 | −4 | −1 |
| Profit before tax | −82 | 12 | −67 | 258 | −80 |
| Tax | −0 | −0 | −0 | −0 | −2 |
| Net profit | −82 | 12 | −67 | 258 | −82 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 394 | 1 676 | 1 633 | 1 870 | 1 875 |
| Equity | 96 | 107 | 1 040 | 1 298 | 1 216 |
| Long-term debt | 1 263 | 1 503 | 533 | 533 | 594 |
| Short-term debt | 36 | 66 | 60 | 39 | 66 |
| Total debt | 1 299 | 1 569 | 593 | 572 | 660 |
EBITDA margin
-7900000.0%
This company
15.8%
Market median
-50000100% vs market
20172021
Equity ratio
64.9%
This company
38.2%
Market median
+70% vs market
20172021
Return on equity
-6.7%
This company
18.4%
Market median
-136% vs market
20172021
Net profit margin
-8200000.0%
This company
8.1%
Market median
-101234668% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UO Liquidator | Liquidator | 2024 |
| Former (2) | ||
VJ Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
RW Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Scandinavian House AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victor Johan Magnus Chang | Chief Executive Officer | 0 companies |
| Ulf Olov Norin | Liquidator | 0 companies |
| Ronald William Domelid | Chief Executive Officer | 0 companies |
| Hans Tommy Andreas Larnefeldt | Deputy Board Member | 0 companies |